Martin Fleck, Warthausen DE
Martin Fleck, Warthausen DE
Patent application number | Description | Published |
---|---|---|
20120157425 | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF - The invention relates to new piperidine derivatives of the formula I | 06-21-2012 |
20120214782 | New compounds, pharmaceutical compositions and uses thereof - The invention relates to new compounds of the formula I | 08-23-2012 |
20120214785 | New compounds, pharmaceutical compositions and uses thereof - The invention relates to new compounds of the formula I | 08-23-2012 |
20130023502 | SUBSTITUTED PYRIDINYL-PYRIMIDINES AND THEIR USE AS MEDICAMENTS - The invention relates to new substituted pyridinyl-pyrimidines of formula | 01-24-2013 |
20130143876 | New piperidine derivatives, pharmaceutical compositions and uses thereof - The invention relates to new piperidine derivatives of the formula I | 06-06-2013 |
20130158004 | Azetidine Derivatives - Azetidine derivatives of which the following is exemplary | 06-20-2013 |
20130165444 | Piperidine Derivatives - Piperidine derivatives of which the following is exemplary | 06-27-2013 |
20130172312 | Azetidine Derivatives - Azetidine derivatives of which the following is exemplary | 07-04-2013 |
20130172316 | New azetidine derivatives, pharmaceutical compositions and uses thereof - The invention relates to new azetidine derivatives of the formula I | 07-04-2013 |
20140100211 | New pyrrolidine derivatives, pharmaceutical compositions and uses thereof - Pyrrolidine derivatives of the formula | 04-10-2014 |
20140213568 | Pyrrolidine derivatives, pharmaceutical compositions and uses thereof - The invention relates to new pyrrolidine derivatives of the formula | 07-31-2014 |
20140315882 | PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF - The invention relates to new pyrrolidine derivatives of the formula | 10-23-2014 |
20140343083 | Pyrrolidine derivatives, pharmaceutical compositions and uses thereof - Pyrrolidine derivatives which are inhibitors of acetyl-CoA carboxylase(s) and their use in the treatment of obesity and type-2 diabetes. An exemplary compound is 2-(4-(1-[5-Chloro-6-(2-hydroxy-2-methyl-propoxy)-pyrimidin-4-yl]-(R)-pyrrolidin-3-yloxy)-phenyl)-N-cyclopropyl-propionamide. | 11-20-2014 |